Press

Building Evidence, Not Seeking Shortcuts: The Real Meaning Behind FDA Breakthrough Device Status When EYE TELL received FDA Breakthrough Device designation, it signaled something fundamental about how regulators view our technology—but the real story goes deeper than the label itself. The distinction matters, especially in a digital health landscape where companies often chase approval pathways as their primary goal. We're taking a different approach: building rigorous, peer-

In digital health, the line between a clever app and a medical device is drawn in clinical data. EYE TELL has crossed that line—not by announcement, but through validation earned from one of the world's most rigorous healthcare institutions: Mayo Clinic. The journey began on the other side of the Pacific. EYE TELL, a Japanese startup developing pupil-based digital biomarker technology, entered the JETRO J-StarX program—a competitive initiative designed to bring high-potential

At a health innovation summit in Brazil, a single thirty-second demonstration changed the trajectory of a conversation—and potentially the reach of early detection technology across one of the world's largest healthcare markets. EYE TELL met Jose (name changed) at the event, a healthcare veteran with deep roots in Brazil's regulatory and clinical ecosystem. After watching the pupil-analysis technology run through its cycle on a smartphone screen, he paused and made a promise

The energy at Asia Society for Global Health's 2026 summit in Hong Kong felt different from other conferences we'd attended. Walking through the registration hall on the first morning, we could sense it—a density of decision-makers, a real appetite for solutions that could scale across Asia's diverse healthcare systems. That appetite would define our three days there. Arriving With Something Different EYE TELL's booth sat in the innovation corridor, positioned alongside hardw

EYE TELL was selected to present and exhibit at the Asia Summit on Global Health (ASGH) 2026, held in Hong Kong in May. The conference brought together healthcare executives, investors, regulators, and innovators from across Asia—a critical platform for healthtech innovation in the region's fastest-growing markets. Our presence marked an important milestone: recognition that smartphone-native early detection is becoming central to how Asian healthcare systems approach prevent